<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Techniques to reduce positive margins in breast-conserving surgery</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Techniques to reduce positive margins in breast-conserving surgery</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Techniques to reduce positive margins in breast-conserving surgery</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Harold J Burstein, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H301361192"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Breast-conserving surgery achieves equivalent local control and disease-specific survival as mastectomy in early-stage breast cancer [<a href="#rid1">1</a>] and is often the preferred technique for primary tumor extirpation for breast cancer patients [<a href="#rid2">2</a>]. Optimal results with breast-conserving surgery require achieving "clear" or negative margins as positive margins have been associated with a twofold increase in local recurrence rate [<a href="#rid3">3</a>].</p><p>Neither radiotherapy nor systemic therapy can substitute for re-excision to clear margins. After initial surgery, reoperation is frequently necessary to obtain negative margins. In the United States, breast-conserving surgery has an aggregate reoperation rate of 21.6 percent even with contemporary imaging methods [<a href="#rid4">4</a>], at a per annum cost of 228 million dollars [<a href="#rid5">5</a>]. </p><p>Techniques that can be used to reduce positive margin rates in breast-conserving surgery are presented here. The indications, techniques, complications, and outcomes of breast-conserving surgery are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/737.html" rel="external">"Overview of the treatment of newly diagnosed, invasive, non-metastatic breast cancer", section on 'Breast-conserving therapy'</a> and  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy"</a>.)</p><p class="headingAnchor" id="H391400092"><span class="h1">DEFINITION OF A POSITIVE MARGIN</span></p><p class="headingAnchor" id="H3293776797"><span class="h2">Invasive disease</span><span class="headingEndMark"> — </span>The definition of an acceptable margin has been the source of historical controversy. A 2014 consensus statement between several professional organizations has suggested that, for patients with invasive disease, a positive margin should be considered as "tumor at ink" [<a href="#rid6">6</a>] (ie, that even a distance of less than 1 millimeter of histologically normal tissue between the tumor and the resected edge is acceptable and therefore does not warrant re-excision as long as there is no tumor at the edge). This consensus also considered this margin appropriate for patients with <strong>both</strong> invasive and in situ disease as long as the intraductal component was not "extensive" (ie, more than 25 percent of the tumor). (See  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy", section on 'Margins for invasive cancer'</a>.)</p><p>The deployment of this definition alone can result in a reduction of re-excision rates as many surgeons had previously required a larger margin to deem a patient as having clear margins [<a href="#rid7">7</a>]. Indeed, in a meta-analysis of 21 nonrandomized studies, pooled odds ratios (ORs) of reoperations were reduced after the publication of the Society of Surgical Oncology-American Society for Radiation Oncology (SSO-ASTRO) margin guideline, albeit to a greater extent in institution-based studies than in population-based studies (OR 0.62, 95% CI 0.52-0.74 versus OR 0.76, 95% CI 0.72-0.80) [<a href="#rid8">8</a>]. However, such retrospective studies cannot prove that adoption of the margin guideline reduced re-excision rates (eg, as opposed to surgeons becoming more proficient at obtaining negative margins with techniques to be discussed below) [<a href="#rid9">9</a>]. </p><p class="headingAnchor" id="H3704036822"><span class="h2">In situ disease</span><span class="headingEndMark"> — </span>For patients who have ductal carcinoma in situ (DCIS) <strong>alone</strong>, a 2016 consensus statement advocated a margin of 2 mm (ie, wider than that for invasive cancer) [<a href="#rid10">10</a>], given that DCIS tends to be multifocal. However, the consensus was less adamant on this mandate, stating that a less than 2 mm margin should not, in and of itself, be an indication for a patient to undergo mastectomy. Given that the National Comprehensive Cancer Network (NCCN) guidelines had previously suggested a margin of ≥1 mm for DCIS [<a href="#rid11">11</a>], the new margin guidelines may increase re-excision rates. This has not yet been well studied. (See  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy", section on 'Margins for DCIS'</a>.)</p><p class="headingAnchor" id="H3628876757"><span class="h1">PREOPERATIVE IMAGING</span><span class="headingEndMark"> — </span>While positive margins may be associated with factors beyond the surgeon's control (eg, tumor biology, multifocal disease with ductal carcinoma in situ [DCIS]), some have suggested that preoperative imaging may help gauge the extent of disease, which may allow surgeons to better plan their surgery and lead to fewer positive margins.</p><p>Prior to breast-conserving surgery, one should perform routine standard imaging with mammography and/or ultrasound, along with clinical examination, to determine the extent of disease. (See  <a class="medical medical_review" href="/d/html/808.html" rel="external">"Diagnostic evaluation of suspected breast cancer"</a>.)</p><p class="headingAnchor" id="H437807490"><span class="h2">Role of MRI</span><span class="headingEndMark"> — </span>Given that magnetic resonance imaging (MRI) is highly sensitive, some have investigated the use of this technology in reducing positive margin rates. Two randomized controlled trials have evaluated the impact of preoperative MRI on margin positivity; neither the COMICE nor the MONET trial found a benefit associated with MRI  (<a class="graphic graphic_table graphicRef117264" href="/d/graphic/117264.html" rel="external">table 1</a>) [<a href="#rid12">12,13</a>]. Choosing Wisely campaign guidelines now suggest that MRI should <strong>not</strong> be routinely performed in all newly diagnosed breast cancer patients [<a href="#rid14">14</a>], as this does not reduce positive margin rates. Rather, preoperative MRI has been associated with higher patient anxiety, more biopsies, and higher mastectomy rates, without any evidence of benefit. (See  <a class="medical medical_review" href="/d/html/14972.html" rel="external">"MRI of the breast and emerging technologies", section on 'Preoperative evaluation of newly diagnosed breast cancer patients'</a>.) </p><p class="headingAnchor" id="H4179367078"><span class="h1">LOCALIZATION OF NONPALPABLE LESIONS</span><span class="headingEndMark"> — </span>Many breast cancers diagnosed in the Western world are not palpable and are only found on screening mammography. In order to remove these tumors, a localization technique is required to guide the surgeon to the lesion in question. While there have been a number of techniques described  (<a class="graphic graphic_table graphicRef117265" href="/d/graphic/117265.html" rel="external">table 2</a>) [<a href="#rid15">15</a>], few randomized controlled trials have compared them [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H1820538940"><span class="h2">Needle localization</span><span class="headingEndMark"> — </span>One of the oldest techniques to localize nonpalpable tumors, which is often considered the historic standard of care, is needle localization. In this technique, a nonpalpable lesion is localized using a fine wire inserted percutaneously under either mammographic or ultrasonographic guidance. The margin clearance rate associated with needle/wire localization is 54 to 90 percent  (<a class="graphic graphic_table graphicRef117265" href="/d/graphic/117265.html" rel="external">table 2</a>) [<a href="#rid15">15,17-22</a>]. This is generally the standard to which all other techniques are compared. </p><p class="headingAnchor" id="H2728942208"><span class="h3">Role of bracketing</span><span class="headingEndMark"> — </span>For patients with a wider span of calcifications, or a larger extent of disease, radiologists can often place more than one wire to "bracket" the area in question. Whether this technique provides better margin clearance remains unclear [<a href="#rid23">23</a>]. Bracketing can also be accomplished with one of the non-wire localization techniques described below.</p><p class="headingAnchor" id="H2957044078"><span class="h2">Radioactive seed localization</span><span class="headingEndMark"> — </span>Radioactive seed localization (RSL) has emerged as an alternative to needle localization for nonpalpable lesions. While this technique offers the ability to place the radioactive seed marker up to one week prior to the operative procedure, obviating the need for wire placement the morning of surgery and thereby a later surgical start time, there are some disadvantages to this technique as well. Because this involves a radioactive seed, radiation safety protocols must be followed, with a diligent record kept of the "chain of possession" of the radioactive seed, from being implanted in the breast, to the removal with the specimen, to the appropriate disposal of the seed. It is also imperative that personnel in the pathology department not cut through the seed while grossing the specimen. Some surgeons have noted some issues with depth perception of the seed marker intraoperatively. </p><p>Many surgeons, particularly those who are experienced with sentinel node biopsy, have found that this technique is easy to master and improves surgical workflow. In terms of margin clearance, however, there are no consistent data to suggest the superiority of either RSL or needle localization  (<a class="graphic graphic_table graphicRef117266" href="/d/graphic/117266.html" rel="external">table 3</a>) [<a href="#rid24">24-30</a>]. The margin clearance rate associated with RSL is 74 to 96 percent  (<a class="graphic graphic_table graphicRef117265" href="/d/graphic/117265.html" rel="external">table 2</a>). </p><p class="headingAnchor" id="H2562505864"><span class="h2">Radio-occult lesion localization</span><span class="headingEndMark"> — </span>Radio-occult lesion localization (ROLL) uses the injection of a radioactive isotope to localize nonpalpable lesions. The short half-life of the isotopes requires injection the morning of surgery and therefore may delay surgery start times. However, ROLL, like RSL, does not require placement of a wire external to the breast. </p><p>A randomized trial evaluating ROLL versus needle localization found more tissue excised using ROLL than with needle localization (71 versus 64 cm<sup>3</sup>) but no difference in the positive margin rate [<a href="#rid23">23</a>]. Similarly, other studies have found no difference in margin positivity rates between ROLL and needle localization or RSL  (<a class="graphic graphic_table graphicRef117266" href="/d/graphic/117266.html" rel="external">table 3</a>) [<a href="#rid31">31-33</a>]. The margin clearance rate associated with ROLL is 66.7 to 87 percent  (<a class="graphic graphic_table graphicRef117265" href="/d/graphic/117265.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H577641046"><span class="h2">Novel localization technologies</span><span class="headingEndMark"> — </span>Several novel tools have been developed to localize nonpalpable lesions with infrared radar (eg, SaviScout), magnetic seeds (eg, MAGSEED), or radiofrequency identification tags. These tools can be implanted days prior to surgery and do not require the use of any radioactive material. While the positive margin rates of the newer tools appear comparable to other methods of nonpalpable lesion localization  (<a class="graphic graphic_table graphicRef117265" href="/d/graphic/117265.html" rel="external">table 2</a>) [<a href="#rid34">34,35</a>], data are limited and not from randomized trials.</p><p class="headingAnchor" id="H2427373386"><span class="h2">Intraoperative ultrasound</span><span class="headingEndMark"> — </span>The use of intraoperative ultrasound (IOUS) has been found to aid localization of both palpable and ultrasonographically visible nonpalpable tumors, improving margin clearance rates beyond palpation or needle localization alone  (<a class="graphic graphic_table graphicRef117267" href="/d/graphic/117267.html" rel="external">table 4</a>) [<a href="#rid36">36-43</a>]. However, most authorities consider IOUS an adjunct to, rather than a stand-alone substitute for, other more established localization techniques such as needle localization, RSL, or ROLL [<a href="#rid16">16,44</a>].</p><p class="headingAnchor" id="H3642288658"><span class="h1">INTRAOPERATIVE MARGIN ASSESSMENT</span><span class="headingEndMark"> — </span>Intraoperative margin assessment techniques are employed to determine the oncological status of the resection margins while the patient is still in the operating room, thereby facilitating immediate margin re-excision when necessary.</p><p class="headingAnchor" id="H3071671762"><span class="h2">Specimen radiography</span><span class="headingEndMark"> — </span>One of the most commonly utilized techniques of intraoperative margin assessment, particularly for nonpalpable tumors, is specimen radiography  (<a class="graphic graphic_diagnosticimage graphicRef103424" href="/d/graphic/103424.html" rel="external">image 1</a>), which can confirm that the lesion in question, plus any preoperatively placed radio-opaque markers identifying the location of the tumor, have been removed. This technique can also identify whether the tumor and/or calcifications extend close to an edge of the specimen such that additional tissue may be resected in that area to lower the risk of a positive margin. (See <a class="local">'Selective margin excision'</a> below.)</p><p class="headingAnchor" id="H2548868596"><span class="h3">Specimen orientation</span><span class="headingEndMark"> — </span>In order to guide further intraoperative excision based on the specimen radiograph, it is critical to appropriately orient the specimen with at least two orthogonal markers [<a href="#rid45">45</a>]. Many surgeons designate the faces of the specimen with a short stitch marking superior and a long stitch marking lateral. Other surgeons mark additional margins, either with charms (such as MarginMap) or by inking the specimen themselves with commercially available inking kits such as MarginMarker. Proper orientation of the specimen is also crucial to planning re-excision based on the final pathology. </p><p class="headingAnchor" id="H3325307844"><span class="h3">Role for 3D specimen radiography</span><span class="headingEndMark"> — </span>Given that traditional specimen radiography produces a two-dimensional image of a three-dimensional specimen, there has been concern that while a specimen may appear to have the lesion in its center, the lesion may actually be on the edge of the specimen if assessed with an orthogonal image. In order to address this concern, systems are available to obtain orthogonal images (eg, the Wedge) or use tomosynthesis technology to obtain fine slices from one end of the specimen to the other, which permits a three-dimensional reconstruction. However, one study that evaluated the impact of taking orthogonal specimen radiographs found that this technology did not dramatically reduce the positive margin rate [<a href="#rid46">46</a>]. Others have also found that tomosynthesis did not significantly improve margin status [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H1465466620"><span class="h2">Frozen section and/or touch imprint cytology</span><span class="headingEndMark"> — </span>Some centers perform intraoperative pathologic evaluation of margins with either frozen section and/or touch imprint cytology. In a 2017 meta-analysis, frozen section and imprint cytology had pooled sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC) values of 86 percent, 96 percent, and 0.96 (9 studies), and 91 percent, 95 percent, and 0.98 (11 studies), respectively [<a href="#rid49">49</a>]. Some, but not all, studies have also found that such techniques reduced the final margin positivity rate  (<a class="graphic graphic_table graphicRef117268" href="/d/graphic/117268.html" rel="external">table 5</a>) [<a href="#rid50">50-55</a>]. </p><p>However, most surgeons (including the author of this topic) do not routinely use frozen section or touch imprint cytology for breast-conserving surgery [<a href="#rid56">56</a>]. A number of concerns beyond reducing positive margin rate should be considered before utilizing this strategy [<a href="#rid45">45</a>]. The first is the availability of appropriately trained pathologists to render a timely evaluation of the margins intraoperatively. If assessment is done using touch imprint cytology, expertise in cytopathology is required. The second issue is that it is impossible to sample the full surface area of a partial mastectomy specimen intraoperatively to provide a comprehensive margin assessment. Frequently, the specimen is grossly evaluated, and the areas that are the most suspicious are sampled for intraoperative assessment. Hence, there remains a false negative rate associated with this procedure. For margin assessment with frozen section, there has been some concern that fatty tissue that has not been properly fixed does not freeze well, and valuable tissue may be lost in the cryostat. Finally, how one assesses the margin, whether tangentially or en face, is a consideration if one wants a margin distance, rather than a qualitative binary judgment of whether there is tumor at the edge of the specimen. </p><p class="headingAnchor" id="H2471229862"><span class="h2">Novel technologies of intraoperative margin assessment</span></p><p class="headingAnchor" id="H1707132608"><span class="h3">MarginProbe</span><span class="headingEndMark"> — </span>There has been significant expansion in the field of devices used to predict positive margins intraoperatively. One of the oldest, and hence most studied, of these is MarginProbe, which utilizes radiofrequency spectroscopy to detect cancer cells at the edge of a specimen. In general, studies have associated the use of this device with a lower positive margin rate and re-excision rate  (<a class="graphic graphic_table graphicRef117269" href="/d/graphic/117269.html" rel="external">table 6</a>) [<a href="#rid57">57-60</a>]. Disadvantages of the use of this technology include the capital cost of both the console as well as the disposable probes. The author of this topic currently does not use this device, given its cost and the lack of evidence that it improves positive margin rates beyond the reduction seen with cavity shave margins and other techniques. (See <a class="local">'Cavity shaving'</a> below.)</p><p class="headingAnchor" id="H584810703"><span class="h3">Lumicell</span><span class="headingEndMark"> — </span>This technology utilizes a protease-activated fluorescent probe that can be used to evaluate the cavity after resection of a tumor to guide further resection of residual disease. While preliminary studies have suggested that this technology holds promise for lowering positive margin rates [<a href="#rid61">61</a>], larger clinical trials are ongoing to evaluate this [<a href="#rid62">62</a>]. Disadvantages of this technology include cost and potential allergic reactions as well as the fact that the LUM015 imaging agent needs to be injected two to six hours prior to the surgical procedure.</p><p class="headingAnchor" id="H1814443217"><span class="h3">Others</span><span class="headingEndMark"> — </span>A number of other intraoperative margin assessment technologies are being developed to optimize margin control and reduce re-excision rate. These technologies rely on imaging, optical spectroscopy, bioimpedance, or mass spectrometry [<a href="#rid63">63</a>]. </p><p class="headingAnchor" id="H3866147520"><span class="h1">CAVITY SHAVING</span></p><p class="headingAnchor" id="H3654090980"><span class="h2">Selective margin excision</span><span class="headingEndMark"> — </span>Following visualization of the tumor and determination of how close it approaches the edge of the specimen with one of the techniques discussed above, selective margin excision can be performed for removal of an area of the cavity that is most likely to harbor additional cancer.</p><p>In the SHAVE trial, in which surgeons were instructed to perform their best partial mastectomy prior to randomization, it was found that those patients who had selective margins excised did not have a significantly lower rate of positive margins than those who did not (38.1 versus 33.7 percent, p = 0.53) [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H1717246060"><span class="h2">Cavity shave margin excision</span><span class="headingEndMark"> — </span>There has been consistent evidence from retrospective [<a href="#rid65">65-69</a>] and prospective randomized controlled trials [<a href="#rid64">64,70,71</a>] that routine excision of cavity shave margins (ie, removal of a small rim of tissue circumferentially from the partial mastectomy cavity) results in at least a 50 percent reduction in the positive margin rate  (<a class="graphic graphic_table graphicRef117270" href="/d/graphic/117270.html" rel="external">table 7</a>). This technique takes 10 minutes or less in the operating room and does not appear to be associated with an increase in complications or worse cosmetic outcome [<a href="#rid64">64</a>]. It can reduce the frequency of reoperation.</p><p>The author of this topic routinely takes cavity shave margins circumferentially around the cavity and orients these to indicate their locations and the aspect of the specimen that is the true margin. </p><p class="headingAnchor" id="H879521713"><span class="h1">AMERICAN SOCIETY OF BREAST SURGEONS "TOOLBOX"</span><span class="headingEndMark"> — </span>In 2015, an American Society of Breast Surgeons consensus conference developed a "toolbox" with the purpose of reducing lumpectomy reoperations and improving cosmetic outcome in breast cancer patients [<a href="#rid45">45</a>]. Most of the "tools" contained in that "toolbox" are discussed above. Individual surgeons may choose from this menu of "tools" based upon their experience and available local resources. </p><p>Available evidence suggests that the impact of intraoperative margin assessment is greater when the baseline positive margin rate is greater than 20 percent [<a href="#rid44">44</a>]. </p><p class="headingAnchor" id="H977737941"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/119871.html" rel="external">"Society guideline links: Breast surgery"</a> and  <a class="medical medical_society_guidelines" href="/d/html/113775.html" rel="external">"Society guideline links: Breast cancer"</a>.)</p><p class="headingAnchor" id="H709221400"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Breast-conserving surgery is equivalent to mastectomy in terms of survival. Positive margins at the time of breast-conserving surgery have been associated with a twofold increase in local recurrence rate. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2014 consensus statement suggested a positive margin to be "tumor at ink" for patients with invasive disease. The same margin is appropriate for patients with <strong>both</strong> invasive and in situ disease, as long as the intraductal component is not "extensive" (ie, more than 25 percent of the tumor). (See <a class="local">'Invasive disease'</a> above and  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy", section on 'Margins for invasive cancer'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2016 consensus statement advocated a wider margin of 2 mm for patients with ductal carcinoma in situ (DCIS) <strong>only</strong>, given that DCIS tends to be multifocal. However, this consensus leaves room for clinical judgment and does not consider a &lt;2 mm margin per se to be an indication for mastectomy. (See <a class="local">'In situ disease'</a> above and  <a class="medical medical_review" href="/d/html/807.html" rel="external">"Breast-conserving therapy", section on 'Margins for DCIS'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Standard preoperative imaging with mammography and/or ultrasound, along with clinical examination, should be performed to gauge the extent of disease. Breast magnetic resonance imaging (MRI) should <strong>not</strong> be performed routinely for all newly diagnosed breast cancer, as it does not reduce positive margin rates  (<a class="graphic graphic_table graphicRef117264" href="/d/graphic/117264.html" rel="external">table 1</a>) and has been associated with higher patient anxiety, more biopsies, and a higher mastectomy rate. (See <a class="local">'Preoperative imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For nonpalpable lesions, localization is critical, but no technique is necessarily superior to another. Standard methods include needle/wire location, radioactive seed localization (RSL), and radio-occult lesion localization (ROLL). Newer techniques include infrared radar (eg, SaviScout), magnetic seeds (eg, MAGSEED), and radiofrequency identification tags  (<a class="graphic graphic_table graphicRef117265" href="/d/graphic/117265.html" rel="external">table 2</a>). (See <a class="local">'Localization of nonpalpable lesions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intraoperative ultrasound may be helpful to reduce positive margin rates if the lesion is ultrasonographically visible but should not be used as a stand-alone localization technique  (<a class="graphic graphic_table graphicRef117267" href="/d/graphic/117267.html" rel="external">table 4</a>). (See <a class="local">'Intraoperative ultrasound'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following excision, the specimen should be oriented with at least two orthogonal markers, and intraoperative specimen radiographs should be performed to verify that the lesion has been completely excised. There is no evidence that three-dimensional specimen radiography reduces positive margin rate. (See <a class="local">'Specimen radiography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some centers use frozen section and/or touch imprint cytology to evaluate margins intraoperatively. However, this technique has not been universally found to reduce positive margin rate  (<a class="graphic graphic_table graphicRef117268" href="/d/graphic/117268.html" rel="external">table 5</a>) and could produce false negative results. (See <a class="local">'Frozen section and/or touch imprint cytology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although there has been significant expansion in the field of devices used to predict positive margins intraoperatively, most intraoperative margin assessment devices remain investigational. (See <a class="local">'Novel technologies of intraoperative margin assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Shaving of the cavity wall following breast-conserving surgery can be performed selectively or circumferentially. We suggest routine circumferential cavity shaving rather than selective or no cavity shaving (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). Data suggest that circumferential, but not selective, cavity shaving reduces the rate of positive margins  (<a class="graphic graphic_table graphicRef117270" href="/d/graphic/117270.html" rel="external">table 7</a>). (See <a class="local">'Cavity shaving'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A "toolbox" of available techniques has been developed by a 2015 American Society of Breast Surgeons Consensus Conference [<a href="#rid45">45</a>]. Available evidence suggests that the impact of intraoperative margin assessment is greater when the baseline positive margin rate is greater than 20 percent. (See <a class="local">'American Society of Breast Surgeons "toolbox"'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233.</a></li><li><a class="nounderline abstract_t">Kaufmann M, Morrow M, von Minckwitz G, et al. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer 2010; 116:1184.</a></li><li><a class="nounderline abstract_t">Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 2014; 21:717.</a></li><li><a class="nounderline abstract_t">Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for re-excision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) database. Ann Surg Oncol 2014; 21:3185.</a></li><li><a class="nounderline abstract_t">Abe SE, Hill JS, Han Y, et al. Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model. J Surg Oncol 2015; 112:443.</a></li><li><a class="nounderline abstract_t">Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol 2014; 21:704.</a></li><li><a class="nounderline abstract_t">Chung A, Gangi A, Amersi F, et al. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer. Ann Surg Oncol 2015; 22 Suppl 3:S422.</a></li><li><a class="nounderline abstract_t">Marinovich ML, Noguchi N, Morrow M, Houssami N. Changes in Reoperation After Publication of Consensus Guidelines on Margins for Breast-Conserving Surgery: A Systematic Review and Meta-analysis. JAMA Surg 2020; 155:e203025.</a></li><li><a class="nounderline abstract_t">Chagpar AB. Defining Why the Re-excision Rate Dropped. Ann Surg Oncol 2019; 26:1176.</a></li><li><a class="nounderline abstract_t">Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. Ann Surg Oncol 2016; 23:3801.</a></li><li class="breakAll">NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Breast Cancer, 2016. Available at: https://www.nccn.org/professionals/physician_gls/default.aspx (Accessed on January 14, 2018).</li><li><a class="nounderline abstract_t">Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010; 375:563.</a></li><li><a class="nounderline abstract_t">Peters NH, van Esser S, van den Bosch MA, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 2011; 47:879.</a></li><li class="breakAll">Choosing Wisely/American Society of Breast Surgeons. Five things physicians and patients should question. 2016. Available at: http://www.choosingwisely.org/wp-content/uploads/2016/06/ASBrS-Choosing-Wisely-List.pdf (Accessed on January 09, 2018).</li><li><a class="nounderline abstract_t">Tóth D, Varga Z, Sebő É, et al. Predictive Factors for Positive Margin and the Surgical Learning Curve in Non-Palpable Breast Cancer After Wire-Guided Localization - Prospective Study of 214 Consecutive Patients. Pathol Oncol Res 2016; 22:209.</a></li><li><a class="nounderline abstract_t">Chan BK, Wiseberg-Firtell JA, Jois RH, et al. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev 2015; :CD009206.</a></li><li><a class="nounderline abstract_t">Hayes MK. Update on Preoperative Breast Localization. Radiol Clin North Am 2017; 55:591.</a></li><li><a class="nounderline abstract_t">Gray RJ, Pockaj BA, Karstaedt PJ, Roarke MC. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg 2004; 188:377.</a></li><li><a class="nounderline abstract_t">Kanat NB, Tuncel M, Aksoy T, et al. Comparison of wire-guided localization and radio-guided occult lesionlocalization in preoperative localization of nonpalpable breast lesions. Turk J Med Sci 2016; 46:1829.</a></li><li><a class="nounderline abstract_t">Tardioli S, Ballesio L, Gigli S, et al. Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience. Anticancer Res 2016; 36:2423.</a></li><li><a class="nounderline abstract_t">Luiten JD, Beek MA, Voogd AC, et al. Iodine seed- versus wire-guided localization in breast-conserving surgery for non-palpable ductal carcinoma in situ. Br J Surg 2015; 102:1665.</a></li><li><a class="nounderline abstract_t">Postma EL, Witkamp AJ, van den Bosch MA, et al. Localization of nonpalpable breast lesions. Expert Rev Anticancer Ther 2011; 11:1295.</a></li><li><a class="nounderline abstract_t">Liberman L, Kaplan J, Van Zee KJ, et al. Bracketing wires for preoperative breast needle localization. AJR Am J Roentgenol 2001; 177:565.</a></li><li><a class="nounderline abstract_t">Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol 2001; 8:711.</a></li><li><a class="nounderline abstract_t">Rarick J, Kimler BF, Tawfik O. Comparison of margin status and lesional size between radioactive seed localized vs conventional wire localized breast lumpectomy specimens. Ann Diagn Pathol 2016; 21:47.</a></li><li><a class="nounderline abstract_t">Bloomquist EV, Ajkay N, Patil S, et al. A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization. Breast J 2016; 22:151.</a></li><li><a class="nounderline abstract_t">Sharek D, Zuley ML, Zhang JY, et al. Radioactive seed localization versus wire localization for lumpectomies: a comparison of outcomes. AJR Am J Roentgenol 2015; 204:872.</a></li><li><a class="nounderline abstract_t">Murphy JO, Moo TA, King TA, et al. Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience. Ann Surg Oncol 2013; 20:4121.</a></li><li><a class="nounderline abstract_t">Hughes JH, Mason MC, Gray RJ, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J 2008; 14:153.</a></li><li><a class="nounderline abstract_t">Taylor DB, Bourke AG, Westcott EJ, et al. Surgical outcomes after radioactive 125I seed versus hookwire localization of non-palpable breast cancer: a multicentre randomized clinical trial. Br J Surg 2021; 108:40.</a></li><li><a class="nounderline abstract_t">Duarte C, Bastidas F, de los Reyes A, et al. Randomized controlled clinical trial comparing radioguided occult lesion localization with wire-guided lesion localization to evaluate their efficacy and accuracy in the localization of nonpalpable breast lesions. Surgery 2016; 159:1140.</a></li><li><a class="nounderline abstract_t">van der Noordaa ME, Pengel KE, Groen E, et al. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium. Eur J Surg Oncol 2015; 41:553.</a></li><li><a class="nounderline abstract_t">Donker M, Drukker CA, Valdés Olmos RA, et al. Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique. Ann Surg Oncol 2013; 20:2569.</a></li><li><a class="nounderline abstract_t">Cox CE, Russell S, Prowler V, et al. A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision. Ann Surg Oncol 2016; 23:3168.</a></li><li><a class="nounderline abstract_t">Dauphine C, Reicher JJ, Reicher MA, et al. A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology. AJR Am J Roentgenol 2015; 204:W720.</a></li><li><a class="nounderline abstract_t">Rahusen FD, Bremers AJ, Fabry HF, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 2002; 9:994.</a></li><li><a class="nounderline abstract_t">Eggemann H, Costa SD, Ignatov A. Ultrasound-Guided Versus Wire-Guided Breast-Conserving Surgery for Nonpalpable Breast Cancer. Clin Breast Cancer 2016; 16:e1.</a></li><li><a class="nounderline abstract_t">James TA, Harlow S, Sheehey-Jones J, et al. Intraoperative ultrasound versus mammographic needle localization for ductal carcinoma in situ. Ann Surg Oncol 2009; 16:1164.</a></li><li><a class="nounderline abstract_t">Moore MM, Whitney LA, Cerilli L, et al. Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg 2001; 233:761.</a></li><li><a class="nounderline abstract_t">Krekel NM, Haloua MH, Lopes Cardozo AM, et al. Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial. Lancet Oncol 2013; 14:48.</a></li><li><a class="nounderline abstract_t">Karanlik H, Ozgur I, Sahin D, et al. Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery. World J Surg Oncol 2015; 13:321.</a></li><li><a class="nounderline abstract_t">Fisher CS, Mushawah FA, Cyr AE, et al. Ultrasound-guided lumpectomy for palpable breast cancers. Ann Surg Oncol 2011; 18:3198.</a></li><li><a class="nounderline abstract_t">Davis KM, Hsu CH, Bouton ME, et al. Intraoperative ultrasound can decrease the re-excision lumpectomy rate in patients with palpable breast cancers. Am Surg 2011; 77:720.</a></li><li><a class="nounderline abstract_t">Gray RJ, Pockaj BA, Garvey E, Blair S. Intraoperative Margin Management in Breast-Conserving Surgery: A Systematic Review of the Literature. Ann Surg Oncol 2018; 25:18.</a></li><li><a class="nounderline abstract_t">Landercasper J, Attai D, Atisha D, et al. Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol 2015; 22:3174.</a></li><li><a class="nounderline abstract_t">Chagpar AB, Butler M, Killelea BK, et al. Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? A prospective cohort study. Am J Surg 2015; 210:886.</a></li><li><a class="nounderline abstract_t">Park KU, Kuerer HM, Rauch GM, et al. Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery. Ann Surg Oncol 2019; 26:1720.</a></li><li><a class="nounderline abstract_t">Mario J, Venkataraman S, Fein-Zachary V, et al. Lumpectomy Specimen Radiography: Does Orientation or 3-Dimensional Tomosynthesis Improve Margin Assessment? Can Assoc Radiol J 2019; 70:282.</a></li><li><a class="nounderline abstract_t">St John ER, Al-Khudairi R, Ashrafian H, et al. Diagnostic Accuracy of Intraoperative Techniques for Margin Assessment in Breast Cancer Surgery: A Meta-analysis. Ann Surg 2017; 265:300.</a></li><li><a class="nounderline abstract_t">Osako T, Nishimura R, Nishiyama Y, et al. Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer. Int J Clin Oncol 2015; 20:1093.</a></li><li><a class="nounderline abstract_t">Cendán JC, Coco D, Copeland EM 3rd. Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins. J Am Coll Surg 2005; 201:194.</a></li><li><a class="nounderline abstract_t">Jorns JM, Visscher D, Sabel M, et al. Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. Am J Clin Pathol 2012; 138:657.</a></li><li><a class="nounderline abstract_t">Weber WP, Engelberger S, Viehl CT, et al. Accuracy of frozen section analysis versus specimen radiography during breast-conserving surgery for nonpalpable lesions. World J Surg 2008; 32:2599.</a></li><li><a class="nounderline abstract_t">Esbona K, Li Z, Wilke LG. Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol 2012; 19:3236.</a></li><li><a class="nounderline abstract_t">D'Halluin F, Tas P, Rouquette S, et al. Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. Breast 2009; 18:248.</a></li><li><a class="nounderline abstract_t">Blair SL, Thompson K, Rococco J, et al. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg 2009; 209:608.</a></li><li><a class="nounderline abstract_t">Schnabel F, Boolbol SK, Gittleman M, et al. A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies. Ann Surg Oncol 2014; 21:1589.</a></li><li><a class="nounderline abstract_t">Sebastian M, Akbari S, Anglin B, et al. The impact of use of an intraoperative margin assessment device on re-excision rates. Springerplus 2015; 4:198.</a></li><li><a class="nounderline abstract_t">Thill M, Dittmer C, Baumann K, et al. MarginProbe®--final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ. Breast 2014; 23:94.</a></li><li><a class="nounderline abstract_t">Allweis TM, Kaufman Z, Lelcuk S, et al. A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. Am J Surg 2008; 196:483.</a></li><li class="breakAll">Lumicell. Products &amp; Technology: Technology Overview. Available at: http://www.lumicell.com/product-technology/technology-overview.php (Accessed on January 14, 2018).</li><li class="breakAll">ClinicalTrials.gov Identifier: NCT03321929. Intraoperative detection of residual cancer in breast cancer. Available at: https://clinicaltrials.gov/ct2/show/NCT03321929?term=03321929&amp;rank=1 (Accessed on March 20, 2018).</li><li><a class="nounderline abstract_t">Leff DR, St John ER, Takats Z. Reducing the Margins of Error During Breast-Conserving Surgery: Disruptive Technologies or Traditional Disruptions? JAMA Surg 2017; 152:517.</a></li><li><a class="nounderline abstract_t">Chagpar AB, Killelea BK, Tsangaris TN, et al. A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer. N Engl J Med 2015; 373:503.</a></li><li><a class="nounderline abstract_t">Kobbermann A, Unzeitig A, Xie XJ, et al. Impact of routine cavity shave margins on breast cancer re-excision rates. Ann Surg Oncol 2011; 18:1349.</a></li><li><a class="nounderline abstract_t">Marudanayagam R, Singhal R, Tanchel B, et al. Effect of cavity shaving on reoperation rate following breast-conserving surgery. Breast J 2008; 14:570.</a></li><li><a class="nounderline abstract_t">Unzeitig A, Kobbermann A, Xie XJ, et al. Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer. Int J Surg Oncol 2012; 2012:725121.</a></li><li><a class="nounderline abstract_t">Janes SE, Stankhe M, Singh S, Isgar B. Systematic cavity shaves reduces close margins and re-excision rates in breast conserving surgery. Breast 2006; 15:326.</a></li><li><a class="nounderline abstract_t">Huston TL, Pigalarga R, Osborne MP, Tousimis E. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 2006; 192:509.</a></li><li><a class="nounderline abstract_t">Jones V, Linebarger J, Perez S, et al. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Ann Surg Oncol 2016; 23:456.</a></li><li><a class="nounderline abstract_t">Dupont E, Tsangaris T, Garcia-Cantu C, et al. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial. Ann Surg 2021; 273:876.</a></li></ol></div><div id="topicVersionRevision">Topic 116309 Version 4.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12393820" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20087962" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24473640" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25047472" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Reasons for re-excision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26374088" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24515565" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26310280" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32857107" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Changes in Reoperation After Publication of Consensus Guidelines on Margins for Breast-Conserving Surgery: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30798449" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Defining Why the Re-excision Rate Dropped.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27527714" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27527714" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20159292" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21195605" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21195605" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26522009" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Predictive Factors for Positive Margin and the Surgical Learning Curve in Non-Palpable Breast Cancer After Wire-Guided Localization - Prospective Study of 214 Consecutive Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26718728" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Localization techniques for guided surgical excision of non-palpable breast lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28411682" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Update on Preoperative Breast Localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15474429" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Radioactive seed localization of nonpalpable breast lesions is better than wire localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28081335" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Comparison of wire-guided localization and radio-guided occult lesionlocalization in preoperative localization of nonpalpable breast lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27127152" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26492349" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Iodine seed- versus wire-guided localization in breast-conserving surgery for non-palpable ductal carcinoma in situ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21916583" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Localization of nonpalpable breast lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11517048" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Bracketing wires for preoperative breast needle localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11597011" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27040931" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Comparison of margin status and lesional size between radioactive seed localized vs conventional wire localized breast lumpectomy specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26696461" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25794081" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Radioactive seed localization versus wire localization for lumpectomies: a comparison of outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23943024" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18248562" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A multi-site validation trial of radioactive seed localization as an alternative to wire localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33640932" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Surgical outcomes after radioactive 125I seed versus hookwire localization of non-palpable breast cancer: a multicentre randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26549819" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Randomized controlled clinical trial comparing radioguided occult lesion localization with wire-guided lesion localization to evaluate their efficacy and accuracy in the localization of nonpalpable breast lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25707349" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23463088" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27469121" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26001262" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464592" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26439275" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Ultrasound-Guided Versus Wire-Guided Breast-Conserving Surgery for Nonpalpable Breast Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19267159" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Intraoperative ultrasound versus mammographic needle localization for ductal carcinoma in situ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11371734" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23218662" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26596699" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21861232" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Ultrasound-guided lumpectomy for palpable breast cancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21679640" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Intraoperative ultrasound can decrease the re-excision lumpectomy rate in patients with palpable breast cancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28058560" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Intraoperative Margin Management in Breast-Conserving Surgery: A Systematic Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26215198" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26255230" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? A prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30877499" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31300313" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Lumpectomy Specimen Radiography: Does Orientation or 3-Dimensional Tomosynthesis Improve Margin Assessment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27429028" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Diagnostic Accuracy of Intraoperative Techniques for Margin Assessment in Breast Cancer Surgery: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25855313" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16038815" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23086766" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18836763" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Accuracy of frozen section analysis versus specimen radiography during breast-conserving surgery for nonpalpable lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22847119" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19515566" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19854401" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24595800" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26020017" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The impact of use of an intraoperative margin assessment device on re-excision rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24291375" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : MarginProbe®--final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18809049" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18809049" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18809049" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28355445" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Reducing the Margins of Error During Breast-Conserving Surgery: Disruptive Technologies or Traditional Disruptions?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26028131" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21046260" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Impact of routine cavity shave margins on breast cancer re-excision rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19000040" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effect of cavity shaving on reoperation rate following breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22312542" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16337123" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Systematic cavity shaves reduces close margins and re-excision rates in breast conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16978962" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26254169" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31290763" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
